Abstract |
Hypoxia-adapted cancer cells in tumors contribute to the pathological progression of cancer. The marine spongean sesquiterpene phenols dictyoceratin-A (1) and -C (2) have been shown to induce hypoxia-selective growth inhibition in cultured cancer cells and exhibit in vivo antitumor effects. These compounds inhibit the accumulation of hypoxia-inducible factor-1α (HIF-1α), which is a drug target in hypoxia-adapted cancer cells, under hypoxic conditions. However, the target molecules of compounds 1 and 2, which are responsible for decreasing HIF-1α expression under hypoxic conditions, remain unclear. In this study, we synthesized probe molecules for compounds 1 and 2 to identify their target molecules and found that both compounds bind to RNA polymerase II-associated protein 3 (RPAP3), which is a component of the R2TP/ Prefoldin-like (PEDL) complex. In addition, RPAP3-knockdown cells showed a phenotype similar to that of compound-treated cells.
|
Authors | Takashi Kawachi, Shun Tanaka, Akinori Fukuda, Yuji Sumii, Andi Setiawan, Naoyuki Kotoku, Motomasa Kobayashi, Masayoshi Arai |
Journal | Marine drugs
(Mar Drugs)
Vol. 17
Issue 3
(Mar 08 2019)
ISSN: 1660-3397 [Electronic] Switzerland |
PMID | 30857246
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Apoptosis Regulatory Proteins
- Biological Products
- Carrier Proteins
- Hydroxybenzoates
- RNA, Small Interfering
- RPAP3 protein, human
- Sesquiterpenes
- dictyoceratin-C
- smenospondiol
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis Regulatory Proteins
- Biological Products
(pharmacology)
- Carrier Proteins
(antagonists & inhibitors, genetics, metabolism)
- Cell Hypoxia
(drug effects)
- Cell Line, Tumor
- Gene Knockdown Techniques
- Humans
- Hydroxybenzoates
(pharmacology)
- Molecular Targeted Therapy
(methods)
- Neoplasms
(drug therapy, pathology)
- Porifera
- RNA, Small Interfering
(metabolism)
- Sesquiterpenes
(pharmacology)
|